Name: UMIN ID:
Unique ID issued by UMIN | UMIN000037294 |
---|---|
Receipt number | R000042517 |
Scientific Title | Study on EGFR tyrosine kinase inhibitor drug Osimertinib resistance in EGFR mutant NSCLC for analysis of immunohistochemistory of tumor tissues. |
Date of disclosure of the study information | 2019/07/06 |
Last modified on | 2021/11/29 14:59:40 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/07/06 14:28:46 | ||
2 | Update | 2020/09/15 17:26:32 | Recruitment status Date of IRB |
|
3 | Update | 2021/11/29 14:58:23 | Recruitment status Last follow-up date Date of closure to data entry |
|
4 | Update | 2021/11/29 14:58:49 | Date of closure to data entry |
|
5 | Update | 2021/11/29 14:59:40 | Number of participants that the trial has enrolled |